The Amadeus Trav-Tech Hackathon 2025 closed on September 16 in Bangkok, Thailand with 11 teams from across the Amadeus ...
Lucas Downey is the co-founder of MoneyFlows, and an Investopedia Academy instructor. Somer G. Anderson is CPA, doctor of accounting, and an accounting and finance professor who has been working in ...
Vertex Pharmaceuticals’ CRISPR-based therapy made history as the first drug of its type, transforming care options for sickle ...
Looking at options history for Vertex Pharmaceuticals (NASDAQ: VRTX) we detected 10 trades. If we consider the specifics of ...
Kintsugi powered by Vertex is built for flexibility, designed to integrate with supported financial systems. This approach ensures that businesses can benefit from AI-powered tax automation regardless ...
Fintel reports that on October 10, 2025, Morgan Stanley maintained coverage of Vertex Pharmaceuticals (NasdaqGS:VRTX) with a Equal-Weight recommendation. Analyst Price Forecast Suggests 18.17% Upside ...
Zacks Investment Research on MSN
Investors Heavily Search Vertex Pharmaceuticals Incorporated (VRTX): Here is What You Need to Know
Vertex Pharmaceuticals (VRTX) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to ...
Vertex broke those barriers with Journavx, the first non-opioid prescription pain killer in more than two decades, earning ...
Vertex Pharmaceuticals has been a clear winner in the pharmaceutical sector. Over the past two decades, this powerhouse has ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback